The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Alere Inc

NYSE: ALR
Last

(U.S.) $39.80

Today's change-0.07 -0.18%
Updated November 26 4:03 PM EST. Delayed by at least 15 minutes.
 

Alere Inc

NYSE: ALR
Last

(U.S.) $39.80

Today's change-0.07 -0.18%
Updated November 26 4:03 PM EST. Delayed by at least 15 minutes.

Alere Inc crosses below 20-day moving average

Alere Inc closed lower Wednesday, dropping (U.S.)$0.07 or 0.18% to (U.S.)$39.80 and crossing below its 20-day moving average. Over the last five days, shares have gained 1.02% and 9.94% year to date. Shares have outperformed the S&P 500 by 6.90% during the last year.

Key company metrics

  • Open(U.S.) $39.82
  • Previous close(U.S.) $39.87
  • High(U.S.) $40.07
  • Low(U.S.) $39.77
  • Bid / Ask-- / --
  • YTD % change+9.94%
  • Volume296,409
  • Average volume (10-day)432,024
  • Average volume (1-month)559,600
  • Average volume (3-month)632,803
  • 52-week range(U.S.) $31.94 to (U.S.) $43.00
  • Beta1.92
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward18.26×
  • Forward PEG1.83×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.04
Updated November 26 4:03 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-5.59%

Alere Inc has a net profit margin of -5.59%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.77%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue736738717772
Total other revenue--------
Total revenue736738717772
Gross profit349340351384
Total cost of revenue388398365388
Total operating expense699747691733
Selling / general / administrative260298280299
Research & development33343938
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)181767
Other operating expenses, total--------
Operating income37-92639
Interest income (expense), net non-operating-52-52-52-52
Gain (loss) on sale of assets--------
Other--------
Income before tax-23-58-21-18
Income after tax-100-52-11-8
Income tax, total77-7-10-10
Net income-86-50-6-4
Total adjustments to net income-5-5-5-5
Net income before extra. items-93-50-6-4
Minority interest0000
Equity in affiliates6254
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-99-55-11-9
Inc. avail. to common incl. extra. items-92-55-11-9
Diluted net income-92-55-11-9
Dilution adjustment0000
Diluted weighted average shares83838282
Diluted EPS excluding extraordinary itemsvalue per share-1.19-0.67-0.14-0.11
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-1.05-0.53-0.05-0.09